Cardiovascular Diseases Research in District of Columbia
Cardiovascular Diseases Research (93.837) awarded $66.4 million to recipients in District of Columbia in 57 grants from fiscal 2021 to 2025, 0.4% of the program's national total. George Washington University (the) received the most, $36.7 million.
- Awarded in District of Columbia$66.4 million
- Awards57
- Share of the program0.4%
- Rank among states32nd of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 33 | $21.0 million |
| FY 2022 | 28 | $13.8 million |
| FY 2023 | 25 | $12.4 million |
| FY 2024 | 26 | $10.7 million |
| FY 2025 | 21 | $8.6 million |
Recipients in District of Columbia
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| George Washington University (the) | Colleges and universities | 28 | $36.7 million |
| Children's Research Institute | Nonprofits | 20 | $18.6 million |
| Georgetown University | Colleges and universities | 3 | $7.3 million |
| Howard University | Colleges and universities | 3 | $3.4 million |
| Vasculonics Inc | Small businesses | 1 | $394,562 |
| National Forum for Heart Disease and Stroke Prevention, Inc. | Nonprofits | 2 | $11,000 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 81 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to District of Columbia?
$66.4 million from fiscal 2021 to 2025, across 57 awards. District of Columbia ranks 32nd of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in District of Columbia?
The largest recipient is George Washington University (the), with $36.7 million in 28 awards. Next are Children's Research Institute and Georgetown University.
Can organizations in District of Columbia apply now?
Yes, 81 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in District of Columbia
- National Railroad Passenger Corporation Grants
- Grants to States for Medicaid
- USAID Foreign Assistance for Programs Overseas
- Federal-State Partnership for Intercity Passenger Rail
- Greenhouse Gas Reduction Fund: National Clean Investment Fund
- Federal Transit Formula Grants
- International Programs to Support Democracy, Human Rights and Labor
- Environmental and Scientific Partnerships and Programs
- International Broadcasting Independent Grantee Organizations
- Highway Planning and Construction